Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (281)	2/22/2002 11:14:58 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 1336

Biotech stock picking portfolio, down 15% ytd. Valentis is the worst performing pick, I did not lose any money on vlts this year, and do not own it anymore. It looks like a perfectly good trading vehicle if a person is happy with 1 3/4 to 2 1/4, and return. I sold half my SNAP at higher levels, still own a few thousand shares...it has not done too much these past couple years, and I've not checked to see what is going on with the MDS Panlabs lawsuit. For that matter, I saw an article on Festo in Nature Biotechnology...for all I know, all these biotech lawsuits are in stasis til Festo (?). Recently I have dabbled in Elan, traded mainly, and done not too much harm. I also own some vgnx, rigl, lsbc, and orch now, small positions on those last two, and just added them today. Amazingly, I have scored a few good trades on some Genset recently, and still maintain a decent position (that is out of the money til the shares return to $10 someday :-( That is all for now, 80% cash.